Author:
Hegele Vanessa,Stoll Paula,Wüst Diego,Ehrenbrink Guilherme,Grazziotin Luiza Raquel,Caregnato Juliana Prohonoski,Lindenmeyer Luciane Pereira
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy
Reference51 articles.
1. Australian Cancer Network Diagnosis and Management of Lymphoma Guidelines Working Party. Guidelines for the diagnosis and management of lymphoma. Sydney: The Cancer Council Australia and Australian Cancer Network; 2005.
2. Zelenetz AD, Abramson JS, Advani RH, Andreadis CB, Byrd JC, Czuczman MS, et al. NCCN Clinical Practice Guidelines in oncology: non-Hodgkin’s lymphomas. J Natl Compr Canc Netw. 2010;8(3):288–334.
3. Rituximabe no tratamento do linfoma difuso de grandes células B [Rituximab in the treatment of diffuse large B cell lymphoma]. Brazilian Bulletin on Health Technology Assessment (BRATS) [serial on the Internet]. 2009;4(10); Available from: http://200.214.130.94/rebrats/brats.php .
4. Cheung MC, Haynes AE, Meyer RM, Stevens A, Imrie KR. Rituximab in lymphoma: a systematic review and consensus practice guideline from Cancer Care Ontario. Cancer Treat Rev. 2007;33(2):161–76.
5. Habermann TM, Weller EA, Morrison VA, Gascoyne RD, Cassileth PA, Cohn JB, et al. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol. 2006;24(19):3121–7.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献